Advanced Solid Tumors: RO7589831 and Pembrolizumab

We are testing a new treatment combining RO7589831 with Pembrolizumab for people with advanced solid tumors. This study aims to understand how effective this combination may be in managing their condition.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
UZ Leuven
General Medical Oncology
Heverlee, Belgium
Rigshospitalet
Rigshospitalet; Fase 1 Enhed - Onkologi
Copenhagen, Denmark
Centre Leon Berard
Medical Oncology
Meyzieu, France

Sponsor: Vividion Therapeutics Inc.
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.